UFraction8 Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 20

UFraction8 General Information

Description

Developer of a scalable cell separation technology designed for new levels of throughput for multiplexed microfluidic devices. The company's technology uses various microfluidic-based devices to perform industrial-scale tasks such as liquid particle processing, cell separation, dewatering, and selective concentration of pathogens, enabling industries to reduce costs compared to three liquid-processing technologies: filtration, flow centrifugation, and flocculation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Suite 1/14, Falkirk Business Hub
  • 45 Vicar Street
  • Falkirk FK1 1LL
  • Scotland, United Kingdom
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Corporate Office
  • Suite 1/14, Falkirk Business Hub
  • 45 Vicar Street
  • Falkirk FK1 1LL
  • Scotland, United Kingdom

UFraction8 Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

UFraction8 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
24. Secondary Transaction - Private Completed Generating Revenue
23. Accelerator/Incubator Completed Generating Revenue
22. Later Stage VC (Series A) 24-Feb-2025 Completed Generating Revenue
21. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
20. Later Stage VC 24-Jan-2022 Completed Generating Revenue
19. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
18. Grant 30-Nov-2020 Completed Generating Revenue
17. Accelerator/Incubator 02-Jun-2020 Completed Generating Revenue
16. Grant 01-Jun-2020 $111K $548K Completed Generating Revenue
15. Grant 01-Dec-2019 $171K $548K Completed Generating Revenue
To view UFraction8’s complete valuation and funding history, request access »

UFraction8 Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
A Ordinary
Ordinary
Seed Ordinary
Seed Ordinary
Seed Ordinary
Seed Ordinary
Ordinary 17,890 $0.000125 $3.35 $3.35 1x $3.35 0.83%
Ordinary 203,390 $0.000125 $0.74 $0.74 1x $0.74 9.4%
To view UFraction8’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

UFraction8 Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a scalable cell separation technology designed for new levels of throughput for multiplexed microfluidic de
Other Devices and Supplies
Falkirk, United Kingdom
10 As of 2026

Lähden, Germany
 

Lund, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

UFraction8 Competitors (2)

One of UFraction8’s 2 competitors is Evodos, a Formerly VC-backed company based in Lähden, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Evodos Formerly VC-backed Lähden, Germany
Alfa Laval Formerly PE-Backed Lund, Sweden
You’re viewing 2 of 2 competitors. Get the full list »

UFraction8 Patents

UFraction8 Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201820944-D0 Microfluid device Inactive 21-Dec-2018
AU-2019409018-A1 Microfluidic device Active 21-Dec-2018
AU-2019409018-B2 Microfluidic device Active 21-Dec-2018
CA-3122054-A1 Microfluidic device Pending 21-Dec-2018
EP-3897982-A1 Microfluidic device Active 21-Dec-2018 B01L3/502753
To view UFraction8’s complete patent history, request access »

UFraction8 Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

UFraction8 Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alwyn Capital Venture Capital Minority
Foresight Group Asset Manager Minority
Old College Capital Venture Capital Minority
Polish Agency for Enterprise Development Government Minority
Scottish Enterprise Growth/Expansion Minority
You’re viewing 5 of 20 investors. Get the full list »

UFraction8 FAQs

  • When was UFraction8 founded?

    UFraction8 was founded in 2017.

  • Where is UFraction8 headquartered?

    UFraction8 is headquartered in Falkirk, United Kingdom.

  • What is the size of UFraction8?

    UFraction8 has 10 total employees.

  • What industry is UFraction8 in?

    UFraction8’s primary industry is Other Devices and Supplies.

  • Is UFraction8 a private or public company?

    UFraction8 is a Private company.

  • What is UFraction8’s current revenue?

    The current revenue for UFraction8 is .

  • How much funding has UFraction8 raised over time?

    UFraction8 has raised $8.93M.

  • Who are UFraction8’s investors?

    Alwyn Capital, Foresight Group, Old College Capital, Polish Agency for Enterprise Development, and Scottish Enterprise are 5 of 20 investors who have invested in UFraction8.

  • Who are UFraction8’s competitors?

    Evodos and Alfa Laval are competitors of UFraction8.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process